BIOLOGIC OUTSOURCING
Annex 1 FAQs: Responding To The 2022 Revision
Viewing the Annex 1 revision as a natural extension of current habits, rather than a burden, allowed for a seamless transition. Since contamination control was already standard, the update simply validated existing excellence.
Providing Value Optimized, Time Saving Oligo Solutions
Whether you are in the beginning research stages or ready to take your product to market, our scalable, high quality, and custom oligo and peptide solutions provide the quantities you need using the most reliable, robust, and cost-effective process available.
Your Roadmap For Efficient Processes
Struggling with mRNA integrity? Discover essential strategies to boost stability in mRNA manufacturing with innovative endonuclease-free DTT and Spermidine chemicals.
Reducing CMC Risk With Proven Analytical And Formulation Expertise
Explore real examples of how this outsourcing partner helps drug sponsors through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.
The Next-Gen Cell Line Development Platform Fueling Biologics Success
Whether you're navigating the challenges of complex biologics or seeking a faster path to the clinic, this discussion sheds light on how innovation in CLD can be a game-changer for your pipeline.
How MilliporeSigma Promotes Quality And Risk Reduction
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
Streamline Your mRNA Purification Steps
Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.
Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing
Watch the fourth and final interview of this 4-part series to learn about Raman applications in bioprocessing from expert Célia Sanchez.
Annex 1 FAQs: Why Is A Good Supplier Partnership Pivotal To Meet Regulatory Expectations?
Struggling to keep pace with EU GMP Annex 1? The right supplier partnership brings critical regulatory insight your team may be missing. Learn how strategic collaboration closes compliance gaps and prepares you for future regulations.
Delivering Reliability With Single-Use Solutions
What does it take to ensure performance and compliance in GMP manufacturing? We optimize single-use systems across upstream and downstream processes, ensuring they perform reliably under GMP conditions.
Your Digital QC Companion For Sterility Testing
Discover software designed to ensure fully accurate data recording in sterility testing and that complies with 21 CFR Part 11 standards for electronic records and signatures.
The Future Of QC: Robotics And Automation
See how pharma 4.0 is revolutionizing the pharmaceutical industry with automation and digitalization to transform microbiological quality control labs into efficient, real-time-monitored environments that enhance productivity.
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.
MilliporeSigma Bio-Expo Live 2024: Downstream Bioprocessing
To optimize efficiencies and reduce contamination risks, we’ve developed a proprietary new film technology for our single-use assemblies offering enhanced strength, flexibility and durability for safe, leakage-free fluid containment.
60-Seconds Of Science: Optimizing Complex Molecule Production
A principal scientist shares how his team overcame key manufacturing challenges in complex bispecific antibody production, highlighting problem-solving strategies and impressive results in this concise educational video.
Meet The Experts: Part 1 - Process Analytical Technology (PAT)
Watch part 1 of this 4-part interview series to learn about process analytical technology (PAT) from expert Stacy Shollenberger.
Discovering A Unique Multimillion Euro Nanotechnology Facility
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
OPTIMA 7000 Fill Line
Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.
GMP-Focused Platform Processes For Microbial, pDNA, And mRNA
Mario Kraft, Director of Process Development at AGC Biologics' Heidelberg facility, explains how platform processes optimize microbial, plasmid DNA, and mRNA production.
Biotherapy Characterization: Cell-Based Assays
MilliporeSigma Senior Scientist Agata Burzawa, MSc, explains how we can provide you with rich data sets to help you understand your complex biotherapy faster. Using limited volumes of samples for testing, our scientists employ leading technologies that integrate cytokine ...
Meet The Experts: PAT, Raman Spectroscopy, And Chemometrics
Gain a better understanding of process analytical technology (PAT), Raman spectroscopy, chemometrics, and Raman applications in bioprocessing.
Expertise In Commercial Fill-Finish For More Than 30 Years
Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.
New Approaches To Tailored Release Profiles
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
Empowering Your Plasmid DNA Workflow
Unlock the full potential of your pDNA purification with advanced chromatography solutions and resins that tackle high viscosity and impurities to ensure superior quality and yield.
Flexible Manufacturing That Fits Your Molecule
Complex molecule manufacturing doesn’t follow an established playbook. See how we combine a thorough understanding of client processes and requirements to generate high-quality biologics
Abzena Capacity Update October 2025: ADC
Explore ThioBridge™ as an efficient site-specific conjugation technology to generate ADCs and other conjugate modalities, such as AOCs and conjugates for diagnostic applications.
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, deve...
Step Inside One Of America's Leading Protein Biologics CDMO Sites
Take a behind-the-scenes look at AGC Biologics’ Seattle campus, one of the most established and productive CDMO facilities in the United States.
Combining Expertise With Best-In-Class Technology
Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner t...
High Capacity, Scalable Cation Exchange Chromatography Membrane For Purification Of Monoclonal Antibody
Overcome binding capacity limitations in mAb purification. A new hydrogel membrane enhances productivity 30x over resins, offering superior loading capacity and consistent, scalable impurity removal.